DK1399482T3 - Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger - Google Patents

Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger

Info

Publication number
DK1399482T3
DK1399482T3 DK02758218T DK02758218T DK1399482T3 DK 1399482 T3 DK1399482 T3 DK 1399482T3 DK 02758218 T DK02758218 T DK 02758218T DK 02758218 T DK02758218 T DK 02758218T DK 1399482 T3 DK1399482 T3 DK 1399482T3
Authority
DK
Denmark
Prior art keywords
bone sialoprotein
antibodies
oncological
issues
determination
Prior art date
Application number
DK02758218T
Other languages
English (en)
Inventor
Franz Paul Armbruster
Markus Karmatschek
Mats Paulsson
Original Assignee
Immundiagnostik Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immundiagnostik Ag filed Critical Immundiagnostik Ag
Application granted granted Critical
Publication of DK1399482T3 publication Critical patent/DK1399482T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Ceramic Products (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK02758218T 2001-06-13 2002-06-06 Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger DK1399482T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01114388 2001-06-13
PCT/EP2002/006219 WO2002100901A2 (de) 2001-06-13 2002-06-06 Bestimmung von bone-sialoprotein in körperflüssigkeiten für onkologische fragestellungen

Publications (1)

Publication Number Publication Date
DK1399482T3 true DK1399482T3 (da) 2009-07-20

Family

ID=8177717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02758218T DK1399482T3 (da) 2001-06-13 2002-06-06 Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger

Country Status (7)

Country Link
US (1) US7790853B2 (da)
EP (1) EP1399482B1 (da)
JP (1) JP4438987B2 (da)
AT (1) ATE425991T1 (da)
DE (1) DE50213368D1 (da)
DK (1) DK1399482T3 (da)
WO (1) WO2002100901A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8282943B2 (en) 2005-05-31 2012-10-09 Ralf Jochem Therapeutic composition for use in the prevention and treatment of bone metastases
EP3182995B1 (en) * 2014-08-19 2019-11-27 Immundiagnostik AG Medicament and apparatus for treating chronic kidney disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340934A (en) * 1989-11-03 1994-08-23 The United States Of Americas As Represented By The Secretary Of Health & Human Services CDNA sequences of human bone matrix proteins
ATE255131T1 (de) * 1991-06-14 2003-12-15 Genentech Inc Humanisierter heregulin antikörper
EP1064554A1 (en) 1998-03-27 2001-01-03 Markus Seibel Determination of the probability of bone metastases in patients with primary carcinomas
CA2355228A1 (en) * 1998-12-22 2000-06-29 University Of Virginia Patent Foundation Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
ATE315229T1 (de) 1999-04-09 2006-02-15 Us Gov Health & Human Serv Komplex aus n-glykolisierten proteinen (siblings) und faktor h

Also Published As

Publication number Publication date
US20050054016A1 (en) 2005-03-10
ATE425991T1 (de) 2009-04-15
EP1399482B1 (de) 2009-03-18
WO2002100901A3 (de) 2003-09-18
WO2002100901A2 (de) 2002-12-19
US7790853B2 (en) 2010-09-07
DE50213368D1 (de) 2009-04-30
JP4438987B2 (ja) 2010-03-24
JP2005508870A (ja) 2005-04-07
EP1399482A2 (de) 2004-03-24

Similar Documents

Publication Publication Date Title
DE69433663D1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
BR0213565A (pt) Anticorpo de anti-tnf alfa modificado
DE60235041D1 (de) Und ihre verwendung
EP2277917A3 (en) B7-H3L cell surface target and a family of antibodies recognizing that target
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
TR200200472T2 (tr) Anti-Erb B2 antikorları ile tedavi için dozajlar
PT1679319E (pt) Métodos para a prevenção e o tratamento da doença de alzheimer (ad)
BR0208603A (pt) Marcadores de tumor para carcinoma de células renais
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
AT500379B8 (de) Tau-proteine
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
BRPI0418766A (pt) anticorpos e moléculas derivadas destes que se ligam às proteìnas steap-1
PT1572087E (pt) Anticorpos contra o antigénio de cancro tmeff2 e suas utilizações
PE20040554A1 (es) Vacunas que comprenden proteinas de fusion
BR0212740B1 (pt) material pulverizado e material cerÂmico fabricado a partir do mesmo.
EP1412388A4 (en) HUMANIZED ANTIBODIES DERIVED FROM DD-3B6 / 22, SPECIFIC OF THE FIBRIN D-DIMER FRAGMENT
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
ATE425991T1 (de) Bestimmung von bone-sialoprotein in kírperflussigkeiten fur onkologische fragestellungen
TR200102655T2 (tr) Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
EP1557466A4 (en) TUMORANT PROPERTIES AND USE THEREOF
EA200600956A1 (ru) Молекулы-антагонисты цитокинов
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
WO2003087841A3 (en) An ephrin-b receptor protein involved in carcinoma
WO2001036485A3 (es) Anticuerpo monocolonal recombinante que reconoce el antigeno ior c2 su uso para el diagnostico y tratamiento de tumores colorectales